Compounded Drugs vs. FDA-Approved Drugs

Key differences between compounded and FDA-approved drugs, including manufacturing standards, testing requirements, and patient safety implications.

Filed under regulation, written for patient-consumer, clinician, pharmacist-compounder, regulator-compliance, evidence level regulatory-update.

Not medically reviewed. Last updated 2026-04-22. Nothing here is medical advice.

Understanding the differences between compounded drugs and FDA-approved drugs is essential for patients, healthcare providers, and industry professionals.

FDA-Approved Drugs

FDA-approved drugs undergo:

• Rigorous preclinical and clinical testing (Phases I–III)
• Review of safety, efficacy, and manufacturing quality
• Post-marketing surveillance (Phase IV)
• Manufactured under validated cGMP processes
• Subject to ongoing FDA inspections and adverse event reporting

Compounded Drugs

Compounded drugs are:

• Not FDA-approved
• Not evaluated for safety, efficacy, or quality before marketing
• Prepared by pharmacies for individual patients (503A) or in larger batches (503B)
• Subject to state pharmacy board and/or FDA oversight
• Not required to undergo clinical trials

Key Differences

| Factor | FDA-Approved | Compounded |

|--------|-------------|-----------|

| Clinical trials | Required | Not required |

| Manufacturing | Validated cGMP | Pharmacy standards |

| FDA review | Pre-market review | No pre-market review |

| Labeling | Standardized | Pharmacy-specific |

| Adverse event reporting | Required | Required for 503B only |

| Insurance coverage | Generally covered | Often not covered |

When Compounding Is Appropriate

Legitimate compounding serves patients who:

• Need a medication in a form not commercially available (different strength, allergen-free)
• Have documented allergies to excipients in commercial products
• Require combination products not commercially available

Safety Considerations

Compounded drugs have been associated with safety incidents, including contamination events and dosing errors. Patients should be informed that compounded products have not undergone the same level of testing as approved drugs.

This article is for educational purposes and does not recommend for or against compounded products.

More guides: All guides, Safety centre, Peptide library.